0001104659-23-101935.txt : 20230919
0001104659-23-101935.hdr.sgml : 20230919
20230919160513
ACCESSION NUMBER: 0001104659-23-101935
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230913
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Narido Richard Clavano
CENTRAL INDEX KEY: 0001956050
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 231263712
MAIL ADDRESS:
STREET 1: 12 HANSEN CT
CITY: MORAGA
STATE: CA
ZIP: 94556
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
3
1
tm2326370-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2023-09-13
1
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001956050
Narido Richard Clavano
C/O NRX PHARMACEUTICALS, INC.
1201 ORANGE STREET, SUITE 600
WILMINGTON
DE
19801
0
1
0
0
Interim CFO
s/ Richard Narido
2023-09-19